يعرض 1 - 20 نتائج من 58 نتيجة بحث عن '"Jarrod P. Holmes"', وقت الاستعلام: 0.58s تنقيح النتائج
  1. 1
    Academic Journal
    Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer

    المؤلفون: Charles L. Wiseman, Jarrod P. Holmes, Carmen Calfa, Shaker R. Dakhil, Saveri Bhattacharya, George E. Peoples, Markus D. Lacher, Miguel Lopez-Lago, Alex Kharazi, Giuseppe Del Priore, Mingjin Chang, Daniel L. Adams, William V. Williams

    المصدر: Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)

    مصطلحات موضوعية: SV-BR-1-GM, breast cancer, immunotherapy, therapeutic cancer vaccine, histocompatibility markers, Trial registration, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

    وصف الملف: electronic resource

    Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

    URL الوصول: https://doaj.org/article/67922cae6ff54870900ebf2a5b42091c

    View record in DOAJ

    أضف إلى المفضلة
  2. 2
    Supplementary Table 1 from Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

    المؤلفون: Elizabeth A. Mittendorf, George E. Peoples, Jarrod P. Holmes, Jason J. Lukas, Anne V. Philips, Na Qiao, Rashmi K. Murthy, Gheath Alatrash, Jennifer K. Litton, Annelies T. Hickerson, Timothy J. Vreeland, Diane Hale, G. Travis Clifton

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112251fcf72ce235da2446e9b1937a23
    https://doi.org/10.1158/1078-0432.22478775.v1

    View record in OpenAIRE

    أضف إلى المفضلة
  3. 3
    Supplementary Table 2 from Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

    المؤلفون: Elizabeth A. Mittendorf, George E. Peoples, Jarrod P. Holmes, Jason J. Lukas, Anne V. Philips, Na Qiao, Rashmi K. Murthy, Gheath Alatrash, Jennifer K. Litton, Annelies T. Hickerson, Timothy J. Vreeland, Diane Hale, G. Travis Clifton

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f220c0e176b244e79134a3c357a8237
    https://doi.org/10.1158/1078-0432.22478772

    View record in OpenAIRE

    أضف إلى المفضلة
  4. 4
    Data from Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

    المؤلفون: Elizabeth A. Mittendorf, George E. Peoples, Jarrod P. Holmes, Jason J. Lukas, Anne V. Philips, Na Qiao, Rashmi K. Murthy, Gheath Alatrash, Jennifer K. Litton, Annelies T. Hickerson, Timothy J. Vreeland, Diane Hale, G. Travis Clifton

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a63e1a074a345baabfa272536a50c6a
    https://doi.org/10.1158/1078-0432.c.6530043

    View record in OpenAIRE

    أضف إلى المفضلة
  5. 5
    Supplementary Figure 1 from Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

    المؤلفون: Elizabeth A. Mittendorf, George E. Peoples, Jarrod P. Holmes, Jason J. Lukas, Anne V. Philips, Na Qiao, Rashmi K. Murthy, Gheath Alatrash, Jennifer K. Litton, Annelies T. Hickerson, Timothy J. Vreeland, Diane Hale, G. Travis Clifton

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1120b850a034484e45c084849c806791
    https://doi.org/10.1158/1078-0432.22478778

    View record in OpenAIRE

    أضف إلى المفضلة
  6. 6
    Abstract P2-14-02: Overall survival following treatment with a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer

    المؤلفون: William Williams, Shaker R Dakhil, Carmen Calfa, Jarrod P Holmes, Saveri Bhattacharya, Jason Lukas, Elizabeth Tan-Chui, George E Peoples, Vivek G Sunkari, Markus D Lacher, Charles L Wiseman

    المصدر: Cancer Research. 82:P2-14

    مصطلحات موضوعية: Cancer Research, Oncology

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2e12ce2e62b800836e58dc9ed1f114c4
    https://doi.org/10.1158/1538-7445.sabcs21-p2-14-02

    View record in OpenAIRE

    أضف إلى المفضلة
  7. 7
    Abstract PS17-20: Response to a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer correlates with tumor grade

    المؤلفون: Jarrod P. Holmes, Shaker R. Dakhil, Vivek G Sunkari, Jason Lukas, Markus D. Lacher, William V. Williams, Elizabeth Tan-Chiu, Charles L. Wiseman, Carmen Calfa, George E. Peoples, Saveri Bhattacharya

    المصدر: Cancer Research. 81:PS17-20

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Advanced breast, Cancer, Tumor cells, medicine.disease, Targeted immunotherapy, Tumor grade, Internal medicine, Medicine, In patient, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::36cb70bbeffaef1fae3a6d775f80b7b8
    https://doi.org/10.1158/1538-7445.sabcs20-ps17-20

    View record in OpenAIRE

    أضف إلى المفضلة
  8. 8
    Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer

    المؤلفون: Jarrod P. Holmes, Timothy J. Vreeland, Elizabeth A. Mittendorf, Anne V. Philips, Jennifer K. Litton, G. Travis Clifton, Annelies T. Hickerson, Jason Lukas, Rashmi Krishna Murthy, George E. Peoples, Diane F. Hale, Gheath Alatrash, Na Qiao

    المصدر: Clinical Cancer Research. 26:2515-2523

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Placebo, law.invention, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Randomized controlled trial, Median follow-up, Trastuzumab, law, Interquartile range, Internal medicine, medicine, skin and connective tissue diseases, Triple-negative breast cancer, business.industry, medicine.disease, 030104 developmental biology, 030220 oncology & carcinogenesis, business, Adjuvant, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c43ef0065fe53ef84bbeead701f3a5af
    https://doi.org/10.1158/1078-0432.ccr-19-2741

    View record in OpenAIRE

    أضف إلى المفضلة
  9. 9
    Intravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study

    المؤلفون: Jarrod P. Holmes, Nancy Joseph-Ridge, Lonnie D. Brent, Janine North, Julio A. Peguero, R. Campbell Garland, Stacia Young

    المصدر: Journal of Infusion Nursing

    مصطلحات موضوعية: Paclitaxel, Urticaria, premedication, medicine.medical_treatment, Sedation, Population, diphenhydramine, Exploratory phase, infusion reaction, antihistamine, elderly, chemistry.chemical_compound, rituximab, Medicine, Humans, education, Adverse effect, General Nursing, Features, Aged, education.field_of_study, business.industry, Diphenhydramine, Cetirizine, chemistry, Anesthesia, intravenous, Antihistamine, Administration, Intravenous, medicine.symptom, hypersensitivity, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29f3fd0fb2f5fbd2fdef7eb26b913e8f
    https://pubmed.ncbi.nlm.nih.gov/34555839

    View record in OpenAIRE

    أضف إلى المفضلة
  10. 10
    Abstract P3-09-08: Efficacy and safety of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer alone and in combination with immune checkpoint inhibitors

    المؤلفون: Markus D. Lacher, Vivek G Sunkari, Shaker R. Dakhil, Charles L. Wiseman, Diane DaSilva, Saveri Bhattacharya, Carmen Calfa, Ajay Kundra, George E. Peoples, Jarrod P. Holmes, William V. Williams, Daniel L. Adams

    المصدر: Cancer Research. 80:P3-09

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Combination therapy, Cyclophosphamide, business.industry, Cancer, Pembrolizumab, medicine.disease, Metastatic breast cancer, Regimen, Breast cancer, Internal medicine, Medicine, Cytokine secretion, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bedcd7882a7b25b05a5d132b14da7290
    https://doi.org/10.1158/1538-7445.sabcs19-p3-09-08

    View record in OpenAIRE

    أضف إلى المفضلة
  11. 11
    Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer

    المؤلفون: Timothy J. Vreeland, Rashmi Krishna Murthy, Annelies T. Hickerson, Phillip M. Kemp Bohan, Na Qiao, Patrick M. McCarthy, Jarrod P. Holmes, Gheath Alatrash, George E. Peoples, Jennifer K. Litton, G. Travis Clifton, Jason Lukas, Anne V. Philips, R. Connor Chick, Elizabeth A. Mittendorf, Diane F. Hale

    المصدر: Clinical immunology (Orlando, Fla.). 225

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Subset Analysis, Adult, Risk, medicine.medical_specialty, Combination therapy, Receptor, ErbB-2, Immunology, Population, HLA-A24 Antigen, Subgroup analysis, Triple Negative Breast Neoplasms, Placebo, Cancer Vaccines, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Trastuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Immunology and Allergy, Humans, Precision Medicine, skin and connective tissue diseases, education, education.field_of_study, business.industry, Granulocyte-Macrophage Colony-Stimulating Factor, medicine.disease, Placebo Effect, Survival Analysis, Peptide Fragments, Intention to Treat Analysis, Gene Expression Regulation, Neoplastic, 030104 developmental biology, Female, Cancer vaccine, Immunotherapy, Neoplasm Recurrence, Local, business, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68a6e4b23b1a3ed338ab948799947733
    https://pubmed.ncbi.nlm.nih.gov/33485895

    View record in OpenAIRE

    أضف إلى المفضلة
  12. 12
    Abstract CT102: Predictors of response to a modified whole tumor cell immunotherapy in patients with advanced breast cancer from two phase I/IIa trials

    المؤلفون: Shaker R. Dakhil, Markus D. Lacher, Daniel L. Adams, Charles L. Wiseman, George E. Peoples, Saveri Bhattacharya, Jarrod P. Holmes, William V. Williams, Carmen Calfa

    المصدر: Cancer Research. 81:CT102-CT102

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Combination therapy, business.industry, Cancer, Pembrolizumab, medicine.disease, Metastatic breast cancer, Regimen, Circulating tumor cell, Internal medicine, Medicine, Hormonal therapy, Progression-free survival, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d27f27114842c23742ba91ecbfda5256
    https://doi.org/10.1158/1538-7445.am2021-ct102

    View record in OpenAIRE

    أضف إلى المفضلة
  13. 13
    Abstract 5588: Clinical and pharmacodynamic responses to a modified whole tumor cell immunotherapy in patients with advanced breast cancer from two phase I-IIa trials

    المؤلفون: Charles L. Wiseman, Saveri Bhattacharya, William V. Williams, Carmen J. Calfa, Daniel L. Adams, Vivekananda (Vivek) Sunkari, Jacqueline Galeas, George E. Peoples, Diane DaSilva, Jarrod P. Holmes, Shaker R. Dakhil, Ajay Kundra, Markus D. Lacher

    المصدر: Cancer Research. 80:5588-5588

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Advanced breast, medicine.medical_treatment, Cancer, Tumor cells, Immunotherapy, medicine.disease, Pharmacodynamics, Internal medicine, medicine, In patient, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b23887cb77c6818d3a5463bec69f5d2c
    https://doi.org/10.1158/1538-7445.am2020-5588

    View record in OpenAIRE

    أضف إلى المفضلة
  14. 14
    Initial safety analysis of a randomized phase II trial of nelipepimut-S + GM-CSF and trastuzumab compared to trastuzumab alone to prevent recurrence in breast cancer patients with HER2 low-expressing tumors

    المؤلفون: Jennifer K. Litton, George E. Peoples, Jason Jerome Lukas, Timothy J. Vreeland, Garth S. Herbert, Jarrod P. Holmes, Rashmi Krishna Murthy, Kaitlin M. Peace, A. Mittendorf Elizabeth, G. Travis Clifton, Diane F. Hale

    المصدر: Clinical immunology (Orlando, Fla.). 201

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Receptor, ErbB-2, Immunology, Breast Neoplasms, Ventricular Function, Left, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Antineoplastic Agents, Immunological, Trastuzumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Immunology and Allergy, Humans, Immunologic Factors, skin and connective tissue diseases, neoplasms, business.industry, Nelipepimut-S, Granulocyte-Macrophage Colony-Stimulating Factor, Stroke Volume, Middle Aged, medicine.disease, Interim analysis, Peptide Fragments, Vaccination, 030104 developmental biology, Toxicity, Peptide vaccine, Immunohistochemistry, Female, Neoplasm Recurrence, Local, business, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d6a75140550eff80b5cad2bc06f21c7
    https://pubmed.ncbi.nlm.nih.gov/30817999

    View record in OpenAIRE

    أضف إلى المفضلة
  15. 15
    Immunologic responses in triple-negative breast cancer patients in a randomized phase IIb trial of nelipepimut-S plus trastuzumab versus trastuzumab alone to prevent recurrence

    المؤلفون: Rashmi Krishna Murthy, Jennifer K. Litton, George E. Peoples, Timothy J. Vreeland, Jessica Campf, Jarrod P. Holmes, Guy T. Clifton, Annelies T. Hickerson, Jason Jerome Lukas, Elizabeth A. Mittendorf, Diane F. Hale

    المصدر: Journal of Clinical Oncology. 37:556-556

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Nelipepimut-S, medicine.disease, PHASE IIB TRIAL, Breast cancer, Trastuzumab, Internal medicine, medicine, Immunohistochemistry, business, Triple-negative breast cancer, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d536fd3e513339d534ff57670c233c05
    https://doi.org/10.1200/jco.2019.37.15_suppl.556

    View record in OpenAIRE

    أضف إلى المفضلة
  16. 16
    Safety and efficacy of a phase I/IIa trial (NCT03066947) of a modified whole tumor cell targeted immunotherapy in patients with advanced breast cancer

    المؤلفون: Jarrod P. Holmes, Daniel E. Adams, Shaker R. Dakhil, Jason Jerome Lukas, Carmen Calfa, George E. Peoples, Markus D. Lacher, Saveri Bhattacharya, Charles L. Wiseman, Elizabeth Tan-Chiu, William V. Williams

    المصدر: Journal of Clinical Oncology. 37:e14026-e14026

    مصطلحات موضوعية: Cancer Research, business.industry, Advanced breast, Cancer, Tumor cells, Transfection, Human leukocyte antigen, medicine.disease, Targeted immunotherapy, Oncology, Antigen, medicine, Cancer research, In patient, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e234584da9bf9b3855a604dca497d61a
    https://doi.org/10.1200/jco.2019.37.15_suppl.e14026

    View record in OpenAIRE

    أضف إلى المفضلة
  17. 17
    Final analysis of nelipepimut-S plus GM-CSF with trastuzumab versus trastuzumab alone to prevent recurrences in high-risk, HER2 low-expressing breast cancer: A prospective, randomized, blinded, multicenter phase IIb trial

    المؤلفون: Timothy J. Vreeland, Elizabeth A. Mittendorf, Annelies T. Hickerson, Rashmi Krishna Murthy, Diane F. Hale, G. Travis Clifton, Jennifer K. Litton, Jarrod P. Holmes, Kaitlin M. Peace, Jason Jerome Lukas, George E. Peoples

    المصدر: Journal of Clinical Oncology. 37:1-1

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Nelipepimut-S, medicine.disease, Preclinical data, PHASE IIB TRIAL, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Trastuzumab, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, 030215 immunology, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::14263376c8e223275a4c76a134ac53d4
    https://doi.org/10.1200/jco.2019.37.8_suppl.1

    View record in OpenAIRE

    أضف إلى المفضلة
  18. 18
    AE37: a novel T-cell-eliciting vaccine for breast cancer

    المؤلفون: George E. Peoples, Constantin N. Baxevanis, Jarrod P. Holmes, Guy T. Clifton, Nathan M. Shumway, Alan K. Sears, M. G. Carmichael, Michael Papamichail, Sathibalan Ponniah, Linda C. Benavides, Jeremy D. Gates, Kevin S. Clive, Sonia A. Perez, Elizabeth A. Mittendorf, David C. Van Echo

    المصدر: Expert Opinion on Biological Therapy. 11:1543-1550

    مصطلحات موضوعية: CD4-Positive T-Lymphocytes, Oncology, medicine.medical_specialty, Receptor, ErbB-2, T cell, medicine.medical_treatment, Clinical Biochemistry, Phases of clinical research, Breast Neoplasms, Cancer Vaccines, Prostate cancer, Lymphocytes, Tumor-Infiltrating, Immune system, Breast cancer, Internal medicine, Drug Discovery, medicine, Animals, Humans, Pharmacology, business.industry, Immunotherapy, medicine.disease, Vaccination, Clinical trial, Treatment Outcome, medicine.anatomical_structure, Immunology, Female, business

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566ce1e29c923a240637835e8b30a9f3
    https://doi.org/10.1517/14712598.2011.616889

    View record in OpenAIRE

    أضف إلى المفضلة
  19. 19
    Comparison of different HER2/neuvaccines in adjuvant breast cancer trials: implications for dosing of peptide vaccines

    المؤلفون: Guy T. Clifton, Jarrod P. Holmes, Jeremy D. Gates, Sathibalan Ponniah, George E. Peoples, Alan K. Sears, Elizabeth A. Mittendorf, Linda C. Benavides, Mark G. Carmichael, Kevin S. Clive

    المصدر: Expert Review of Vaccines. 10:201-210

    مصطلحات موضوعية: Receptor, ErbB-2, medicine.medical_treatment, Immunology, Breast Neoplasms, Pharmacology, Cancer Vaccines, HER2/neu, Immune system, Breast cancer, Adjuvants, Immunologic, Antigens, Neoplasm, In vivo, Drug Discovery, medicine, Humans, Dosing, Clinical Trials as Topic, biology, business.industry, medicine.disease, Peptide Fragments, Clinical trial, Treatment Outcome, Vaccines, Subunit, biology.protein, Molecular Medicine, Female, business, Adjuvant, Ex vivo

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e5d4a8554eedfbb0fca8c18e417ea1
    https://doi.org/10.1586/erv.10.167

    View record in OpenAIRE

    أضف إلى المفضلة
  20. 20
    Pre-specified interim analysis of a randomized phase IIb trial of trastuzumab + nelipeptimut-S (NeuVax) vs trastuzumab for the prevention of recurrence demonstrates benefit in triple negative (HER2 low-expressing) breast cancer patients

    المؤلفون: Tommy A. Brown, Timothy J. Vreeland, Guy T. Clifton, Jarrod P. Holmes, Kaitlin M. Peace, George E. Peoples, John W. Myers, Julia M. Greene, Diane F. Hale, Doreen O. Jackson, Elizabeth A. Mittendorf

    المصدر: Annals of Oncology. 29:viii400

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Hematology, medicine.disease, Interim analysis, PHASE IIB TRIAL, 03 medical and health sciences, 030104 developmental biology, Breast cancer, Trastuzumab, Internal medicine, Medicine, NeuVax, business, Triple negative, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f6e12827ce7a56768335bc36b6ba45a2
    https://doi.org/10.1093/annonc/mdy288.001

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء